Patents by Inventor Fulvio Gadient

Fulvio Gadient has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2'-O, N.sup.6 -disubstituted and 2'-O, N.sup.6, 2-trisubstituted adenosines and their medicinal uses
    Patent number: 5534503
    Abstract: Adenosines derivatives of the formula ##STR1## wherein R.sub.1 is allyl, methallyl, straight or branched chain (C.sub.3-7)alkynyl, (C.sub.3-8)cycloalkyl, or phenyl mono- or independently of one another di-substituted by halogen having an atomic number of from 9 to 35, (C.sub.1-4)alkyl, (C.sub.1-4)alkoxy, or CF.sub.3 ; R.sub.2 is hydrogen or C(.sub.1-4)alkyl, and R.sub.3 is (C.sub.1-4)alkyl, are useful for protecting vascular endothelium, for lowering blood lipid levels, and for treating raised blood pressure.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: July 9, 1996
    Assignee: Sandoz Ltd.
    Inventor: Fulvio Gadient
  • Antihypertensive 9-(2,N.sup.6 -disubstituted adenyl) ribofuranuronic acid derivatives
    Patent number: 5219840
    Abstract: N.sup.6, 2-disubstituted or 2-substituted 1'-desoxy-1'-(6-amino-9-purinyl)-.beta.-D-ribofuranuronic acid amides, N-substituted amides, N,N-disubstituted amides, thioamides, N-substituted thioamides and N,N-disubstituted thioamidesare effective against raised blood pressure.
    Type: Grant
    Filed: May 1, 1991
    Date of Patent: June 15, 1993
    Assignee: Sandoz Ltd.
    Inventors: Fulvio Gadient, Arnold Vogel
  • Furanuronic acid derivatives, process for their production and their use
    Patent number: 4855288
    Abstract: 1'-desoxy-1'-(6-amino-9-purinyl)-.beta.-D-ribofuranuronic acid thioamides of formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 possess various definitions given in claim 2, are effective against raised blood pressure.
    Type: Grant
    Filed: December 14, 1987
    Date of Patent: August 8, 1989
    Assignee: Sandoz Ltd.
    Inventors: Fulvio Gadient, Arnold Vogel
  • Diazepinoindoles useful for treating depression, schizophrenia, social withdrawal or anxiety and pharmaceutical compositions containing them
    Patent number: 4673674
    Abstract: Diazepinoindoles or pharmaceutically acceptable acid addition salts thereof are useful as antidepressant, conflict reducing or neuroleptic agents.
    Type: Grant
    Filed: February 21, 1985
    Date of Patent: June 16, 1987
    Assignee: Sandoz Pharmaceuticals Corp.
    Inventor: Fulvio Gadient
  • 1-Phenyl-azepinoindoles
    Patent number: 4478750
    Abstract: A 1,2,3,4,5,6-hexahydro-6-phenyl-azepino[4,5-b]indole, or a pharmaceutically acceptable acid addition salt thereof is a useful neuroleptic, anti-depressant and anti-allergic agent.
    Type: Grant
    Filed: June 7, 1982
    Date of Patent: October 23, 1984
    Assignee: Sandoz Ltd.
    Inventor: Fulvio Gadient
  • N-Phenylindoline derivatives, and pharmaceutical compositions containing them
    Patent number: 4272533
    Abstract: 2-aminoethyl-1-phenylindolines are useful as anti-diabetic and anti-obesity agents.
    Type: Grant
    Filed: August 27, 1979
    Date of Patent: June 9, 1981
    Assignee: Sandoz Ltd.
    Inventors: Fulvio Gadient, Rudolf Suess
  • Quaternary tropane ethers
    Patent number: 4237296
    Abstract: The present invention concerns tropane derivatives of the formula ##STR1## wherein R.sub.1 and R.sub.2 are, independently, hydrogen, halogen, trifluoromethyl, lower alkyl or lower alkoxy,R.sub.3 and R.sub.4 are, independently, lower alkyl, n is 0, 1 or 2, and p0 X.sup..crclbar. is the anion of a pharmaceutically acceptable salt-forming acid.
    Type: Grant
    Filed: January 29, 1979
    Date of Patent: December 2, 1980
    Assignee: Sandoz Ltd.
    Inventor: Fulvio Gadient
  • Tricyclo piperidino ketones and soporific compositions thereof
    Patent number: 4072756
    Abstract: The invention concerns novel compounds of the formula: ##STR1## wherein n is 1, 2 or 3 R.sub.1 is lower alkylR.sub.2 is hydrogen or lower alkyl andA is a tricyclic moiety,Useful as sedative-neuroleptic, muscle-relaxant and sleep-promoting agents.
    Type: Grant
    Filed: May 13, 1976
    Date of Patent: February 7, 1978
    Assignee: Sandoz Ltd.
    Inventors: Anton Ebnother, Jean-Michel Bastian, Fulvio Gadient, Andre Stoll
  • 6,11-Dihydro-11-oxo-dibenzo[b,e]thiepine-2-acetic acids
    Patent number: 3946036
    Abstract: The present invention provides compounds of formula I, ##SPC1##whereinR.sub.1 is hydrogen, fluorine, chlorine, bromine, hydroxyl, lower alkyl, lower alkoxy, amino or lower acylamino, andR.sub.2 is hydrogen or lower alkyl,Useful as antiphlogistic and anti-arthritic agents.
    Type: Grant
    Filed: September 9, 1974
    Date of Patent: March 23, 1976
    Assignee: Sandoz Ltd.
    Inventor: Fulvio Gadient